Corrigendum to “SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo” [Cancer Lett. 351 (2014) 143–50]
Titel:
Corrigendum to “SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo” [Cancer Lett. 351 (2014) 143–50]
Auteur:
Wang, Lu Ai, Jing Shen, Yanyan Zhang, Haotian Peng, Xia Huang, Min Zhang, Ao Ding, Jian Geng, Meiyu